logo
Select company
Select metric
$ 39.03MNet Cash Flow - Financing
VS
Market
23
Sector
23
Industry
13
History
24
$ 4.08Close
$ 1.96 - $ 4.24 52-Week Range
Ticker Information

Ticker

IMDX

Company Name

INSIGHT MOLECULAR DIAGNOSTICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

INSIGHT MOLECULAR DIAGNOSTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMDX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 39.03M
3/31/2025$ 48.99M
12/31/2024$ 20.43M
9/30/2024$ 9.56M
6/30/2024$ 9.79M
3/31/2024$ 12.21M
12/31/2023$ 12.19M
9/30/2023$ 12.12M
6/30/2023$ 11.57M
3/31/2023$ 36.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 30.16M.
  • Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average CF - Financing has been $ 35.43M.
  • The median CF - Financing for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was $ 32.9M
  • INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest CF - Financing over the past 5 years at $ 85.11M.
  • The lowest CF - Financing recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe $ 8.14M

INSIGHT MOLECULAR DIAGNOSTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
VNRX : VOLITIONRX LTD $ 17.23MARMP : ARMATA PHARMACEUTICALS INC $ 9.93MCBUS : CIBUS INC $ 60.18MPYXS : PYXIS ONCOLOGY INC $ 1.64MNTRB : NUTRIBAND INC $ 5.19MPRPH : PROPHASE LABS INC $ 8.79MLUCD : LUCID DIAGNOSTICS INC $ 49.99MPSTV : PLUS THERAPEUTICS INC $ 15.2MBNBX : APPLIED DNA SCIENCES INC $ 7.54MALGS : ALIGOS THERAPEUTICS INC $ 101.66M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

IMDX - Net Cash Flow - Financing, Last 5 years

$ 8.14M

Minimum

Mar 31, 2022

$ 85.11M

Maximum

Mar 31, 2021

$ 35.43M

Average

$ 32.9M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.25M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.25M